Inizio
Generated by Meeveem AI
"Global commercialization partner for health and life sciences companies"
New York, NY
•1000+ Employees
•Health Advisory
About Inizio
Inizio partners with health and life sciences companies across the full commercialization journey, from early-stage clinical development through to loss of exclusivity. With more than 10,500 experts across 50 countries, the company combines industry knowledge with data-driven insights, advanced technology, and AI to simplify complex challenges and accelerate decision-making at every pivotal moment. Formed in 2022 through the merger of Ashfield and Huntsworth, Inizio operates through five specialized business units. The company supported over 60% of top pharmaceutical product launches in recent years, delivering tailored solutions that maximize asset value, unlock market access, and help more patients access treatments faster.
Illustrative visual - may not reflect the actual offering.
Illustrative visual - may not reflect the actual offering.
10500
Team Members
2022
Founded
Private Equity
Funding
Hybrid
Work Environment
Our Vision
A world where every breakthrough therapy reaches the patients who need it, without barriers of complexity, access, or delay, transforming global healthcare outcomes for all.
Our Mission
At Inizio, our mission is to help health and life sciences companies get more people the treatments they need, faster.